PPPrateek Paul

Prateek Paul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prateek Paul has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Ajaswrata Dutta

    Radiomitigation Research Department, Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organization (DRDO), Brig. S.K Mazumdar Marg, Delhi, India

    1 shared publication
  • Dhvani Sandip Vora

    Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, 13400 E. Shea Blvd. Scottsdale, MN 55905

    1 shared publication
  • Jaspreet Kaur Dhanjal

    Department of Computational Biology, Indraprastha Institute of Information Technology Delhi, Okhla Industrial Estate, Phase III, New Delhi, 110020, India

    1 shared publication
  • Shashank Yadav

    Department of Biomedical Engineering, University of Arizona , 1200 E. University Blvd., Tucson, AZ 85721

    1 shared publication
  • Subodh Kumar

    Stem Cell & Tissue Engineering Research Group, Institute of Nuclear Medicine & Allied Sciences (INMAS), Defence Research and Development Organisation (DRDO), Delhi, India

    1 shared publication
  • Suchitra Sharma

    Institute of Animal Nutrition and Functional Plant Compounds, University of Veterinary Medicine, Veterinärplatz 1, 1210 Vienna, Austria

    1 shared publication

Latest Publications

  • Open Access

    Raloxifene drug enhances stem cell proliferation by inducing the expression of STAT3

    by Subodh Kumar, Prateek Paul, Suchitra Sharma, Ajaswrata Dutta, Yogesh Kumar Verma

    Cell proliferation is a complex process that requires the coordination of multiple signaling cascades. In this study, we aimed to identify cell Raloxifene to induce cell proliferation and tissue repair. Raloxifene is an estrogen receptor modulator that helps with osteoporosis post-menopause. We evaluated their role in cell proliferation and molecular mechanism of action via molecular docking, Molecular dynamic (MD) simulation, MM-PBSA analysis, and PCA analysis. Furthermore, the in vitro cell proliferation was evaluated using MTT, BrdU, Ki-67 immunochemistry, cell cycle analysis and in vivo for a whole-body irradiated model for survival by inducing cell proliferation. Our findings suggested that the identified drug, Raloxifene, interacts with STAT3 with -8.1 Kcal/mol binding energy and 0.126±0.177 nm RMSD. In vitro results showed that Raloxifene significantly (pvalue2.5) induced STAT3, followed by Cyclin B, thus enhancing cell proliferation. We also observed a 100 % survival rate in the Raloxifene-treated group compared to the irradiated group. This work may be helpful accelerating proliferation of soft tissue repair in case of combat injuries, radiation injuries, blood pharming, and hematopoietic reconstitution.

  • Open Access

    graphB3—an interpretable graph learning approach for predicting blood–brain barrier permeability

    by Sumit Kumar, Shashank Yadav, Dhvani Sandip Vora, Prateek Paul, Jaspreet Kaur Dhanjal

    Blood–Brain Barrier (BBB) is a specialized vascular structure that protects the brain by controlling what can pass from the bloodstream into the central nervous system. BBB’s highly selective nature prevents neurotoxins and foreign substances, including drugs, from entering the brain. Understanding and predicting whether a drug can cross the BBB is hence crucial in brain-related diseases. Over the past two decades, deep learning in drug discovery has witnessed an upward trend to reduce the cost, labor, and time for finding potential drugs. Majority of recent deep learning-based studies use molecular-level physiochemical properties of known drugs, which are limited and may not be sufficient to capture patterns. Here, we propose a parameter efficient Graph Convolution-based model, graphB3, which uses detailed information about the atoms in a molecule to predict the BBB permeability of drug candidates, outperforming existing methods. In addition to high predictive performance, graphB3 also offers an explanation of which parts of the molecule are most important for crossing the BBB. graphB3 can be employed to discover new BBB-permeable compounds and potential drugs. A free and easy-to-use graphB3 web server is available at https://dhanjal-lab.iiitd.edu.in/graphb3.html, and a standalone tool available at https://github.com/dhanjal-lab/graphB3.